FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Fate Therapeutics
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
University of California, San Francisco
National Institutes of Health Clinical Center (CC)
Ohio State University Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
City of Hope Medical Center
Sana Biotechnology
University of Maryland, Baltimore
Jonsson Comprehensive Cancer Center
Roswell Park Cancer Institute
Case Comprehensive Cancer Center
University Health Network, Toronto
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Gilead Sciences
Fate Therapeutics
Bristol-Myers Squibb
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
First Affiliated Hospital of Wenzhou Medical University
University of Maryland, Baltimore
Hoffmann-La Roche
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Emory University
AbbVie
Northwestern University
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center